Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory N Fuller

Showing results (191-200 of 245) with videos related to

Pageof 25
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2003
West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature reviewDavid S Hong, Kalen L Jacobson, Issam I Raad, et al.
Clinical Neurosurgery|March 11, 2010
The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitorAmy B Heimberger, Ling-Yuan Kong, Mohamed Abou-Ghazal, et al.
Journal of the National Cancer Institute|May 8, 2003
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathwayJuan Fueyo, Ramon Alemany, Candelaria Gomez-Manzano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cellsLing-Yuan Kong, Mohamed K Abou-Ghazal, Jun Wei, et al.
Journal of the National Cancer Institute|June 28, 2018
The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in GliomaKhatri Latha, Jun Yan, Yuhui Yang, et al.
Oncogene|January 16, 2002
Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequencesYoshiaki Adachi, Nirmala Chandrasekar, Yoshiaki Kin, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 9, 2023
Subependymomas of the fourth ventricle: To operate or not to operate?Ali S Haider, Ian E McCutcheon, Chibawanye I Ene, et al.
Clinical Neuropathology|December 1, 2018
ATRX protein loss and deregulation of PI3K/AKT pathway is frequent in pilocytic astrocytoma with anaplastic featuresAdriana Olar, Diep Tran, Vidya P Mehta, et al.
The Lancet. Oncology|September 22, 2018
Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trialEric Jonasch, Ian E McCutcheon, Dan S Gombos, et al.
Oncogene|April 4, 2025
Retraction Note: Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cellsSanjeeva Mohanam, Sushma L Jasti, Sudha R Kondraganti, et al.
Pageof 25

Showing results (191-200 of 245) with videos related to

Sort By:
Pageof 25
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2003
West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature reviewDavid S Hong, Kalen L Jacobson, Issam I Raad, et al.
Clinical Neurosurgery|March 11, 2010
The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitorAmy B Heimberger, Ling-Yuan Kong, Mohamed Abou-Ghazal, et al.
Journal of the National Cancer Institute|May 8, 2003
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathwayJuan Fueyo, Ramon Alemany, Candelaria Gomez-Manzano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cellsLing-Yuan Kong, Mohamed K Abou-Ghazal, Jun Wei, et al.
Journal of the National Cancer Institute|June 28, 2018
The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in GliomaKhatri Latha, Jun Yan, Yuhui Yang, et al.
Oncogene|January 16, 2002
Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequencesYoshiaki Adachi, Nirmala Chandrasekar, Yoshiaki Kin, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 9, 2023
Subependymomas of the fourth ventricle: To operate or not to operate?Ali S Haider, Ian E McCutcheon, Chibawanye I Ene, et al.
Clinical Neuropathology|December 1, 2018
ATRX protein loss and deregulation of PI3K/AKT pathway is frequent in pilocytic astrocytoma with anaplastic featuresAdriana Olar, Diep Tran, Vidya P Mehta, et al.
The Lancet. Oncology|September 22, 2018
Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trialEric Jonasch, Ian E McCutcheon, Dan S Gombos, et al.
Oncogene|April 4, 2025
Retraction Note: Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cellsSanjeeva Mohanam, Sushma L Jasti, Sudha R Kondraganti, et al.
Pageof 25